Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Ulrika Ericson

Ulrika Ericson

Associate professor

Ulrika Ericson

TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.

Author

  • Isabel Drake
  • Peter Wallström
  • George Hindy
  • Ulrika Ericson
  • Bo Gullberg
  • Anders Bjartell
  • Emily Sonestedt
  • Marju Orho-Melander
  • Elisabet Wirfält

Summary, in English

Variation in transcription factor 7-like 2 (TCF7L2), the strongest genetic risk factor for type 2 diabetes (T2D), may play a role in prostate cancer (PCa) depending on lifestyle factors. The aims of this study were to determine if TCF7L2 rs7903146 is associated with risk of PCa and if the association is modified by lifestyle factors independently of T2D status.

Department/s

  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Nutrition Epidemiology
  • Diabetes - Cardiovascular Disease
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
  • Urological cancer, Malmö
  • EpiHealth: Epidemiology for Health

Publishing year

2014

Language

English

Pages

1161-1170

Publication/Series

The Prostate

Volume

74

Issue

12

Document type

Journal article

Publisher

John Wiley and Sons

Topic

  • Obstetrics, Gynecology and Reproductive Medicine

Status

Published

Research group

  • Nutrition Epidemiology
  • Diabetes - Cardiovascular Disease
  • Urological cancer, Malmö

ISBN/ISSN/Other

  • ISSN: 0270-4137